Latest filing published 03 Jul 2026 for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares, €2.6M.
Lai Degui discloses dealings in Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares to HKEX. The record holds 5 filings, for trades running from 24 June 2026 to 30 June 2026.
Every open-market trade on record is a sale: 5 sales worth €5.6M.
The latest filing, published on 3 July 2026, reports an open-market sale of €2.6M in Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. - H Shares. Filings reach the HKEX feed a median of 2 days after the trade. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 1 declaration